- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Specialty Pharmaceuticals
Orexigen Therapeutics Inc+ Add to Watchlist
OREX:US5.3000 USD 0.0800 1.49%
As of 20:10:00 ET on 04/17/2014.
Company Profile for Orexigen Therapeutics Inc (OREX)
Orexigen Therapeutics Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of pharmaceutical products for the treatment of the central nervous system, or CNS, disorders with an initial focus on obesity.
Orexigen Therapeutics Inc
Key Executives for Orexigen Therapeutics Inc (OREX)
|Michael Narachi "Mike"President/CEO||Mark D BoothChief Commercial Officer|
|Joseph P Hagan "Jay"Chief Bus Officer/Acting CFO||Heather D TurnerSenior VP/Secretary/Gen Cnsl|
|Preston S KlassenSenior VP:Product Development|